Literature DB >> 2336870

Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies.

B Brochier1, I Thomas, B Bauduin, T Leveau, P P Pastoret, B Languet, G Chappuis, P Desmettre, J Blancou, M Artois.   

Abstract

The vaccination of wild animals against rabies has been developed most extensively in Europe. Experiments have demonstrated the efficacy of a vaccinia-rabies recombinant virus administered by the oral route in foxes. The innocuity of this vaccine was tested in the target species as well as in several non-target wild and domestic species. Because of its safety and heat-stability, this recombinant virus should offer an excellent alternative to the attenuated strains of rabies virus currently used in the field. A large scale field trial was conducted in Belgium in October 1988 to assess the efficacy of this new vaccine-bait systems.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2336870     DOI： 10.1016/0264-410x(90)90129-a

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  13 in total

1.  Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection.

Authors:  D L Lodmell; J W Sumner; J J Esposito; W J Bellini; L C Ewalt
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 2.  Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.

Authors:  D T O'Hagan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

3.  Assessment of an oral Mycobacterium bovis BCG vaccine and an inactivated M. bovis preparation for wild boar in terms of adverse reactions, vaccine strain survival, and uptake by nontarget species.

Authors:  Beatriz Beltrán-Beck; Beatriz Romero; Iker A Sevilla; Jose A Barasona; Joseba M Garrido; David González-Barrio; Iratxe Díez-Delgado; Esmeralda Minguijón; Carmen Casal; Joaquín Vicente; Christian Gortázar; Alicia Aranaz
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

4.  Rabies vaccine preserved by vaporization is thermostable and immunogenic.

Authors:  Todd G Smith; Marina Siirin; Xianfu Wu; Cathleen A Hanlon; Victor Bronshtein
Journal:  Vaccine       Date:  2015-03-23       Impact factor: 3.641

5.  Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine.

Authors:  K M Charlton; M Artois; L Prevec; J B Campbell; G A Casey; A I Wandeler; J Armstrong
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Assessment of the immunogenicity of rabies vaccine preserved by vaporization and delivered to the duodenal mucosa of gray foxes (Urocyon cinereoargenteus).

Authors:  Todd G Smith; Xianfu Wu; James A Ellison; Ashutosh Wadhwa; Richard Franka; Gregory L Langham; Brianna L Skinner; Cathleen A Hanlon; Victor L Bronshtein
Journal:  Am J Vet Res       Date:  2017-06       Impact factor: 1.156

7.  The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur.

Authors:  P P Pastoret; B Brochier
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

8.  Resistance of mice vaccinated with rabies virus internal structural proteins to lethal infection.

Authors:  Y Takita-Sonoda; H Fujii; K Mifune; Y Ito; M Hiraga; A Nishizono; K Mannen; N Minamoto
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Characterization of rabies glycoprotein expressed in yeast.

Authors:  S R Klepfer; C Debouck; J Uffelman; P Jacobs; A Bollen; E V Jones
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Cross-protection of mice against a global spectrum of rabies virus variants.

Authors:  D L Lodmell; J S Smith; J J Esposito; L C Ewalt
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.